Lytix Biopharma to present at the 'Frontiers in Cancer Immunotherapy 2023', invited by New York Academy of Sciences

/PRNewswire/ -- Lytix Biopharma - Lytix Biopharma AS ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company - is pleased to announce that...

Related Keywords

United States ,Norway ,Rekdal ,Møg Romsdal ,New York ,New York Academy Of Sciences ,Norwegian ,Lytix Biopharma ,Peter Nordby ,Lytix Euronext ,Lorenzo Galluzzi ,Md Anderson Cancer Center ,York Academy Of Sciences ,Infinity Pharmaceuticals ,James Allison University Of Texas ,Nina Bhardwaj Icahn School Of Medicine ,Euronext Growth Oslo ,New York Academy ,Weill Cornell ,Cancer Vaccines ,Clinically Viable Tumor Directed Strategies ,Enable Superior Immunostimulation ,Wednesday May ,Nobel Laureate ,James Allison ,Cancer Center ,Nina Bhardwaj ,Icahn School ,Mount Sinai ,Washington University School ,Enable Medicine ,Gritstone Bio ,Lytix Biopharma As ,